Pair Name | Deoxyelephantopin, Cisplatin | ||
Phytochemical Name | Deoxyelephantopin (PubChem CID: 6325056 ) | ||
Anticancer drug Name | Cisplatin (PubChem CID: 5702198 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Drug Name | Cisplatin |
Adverse Reactions | Myelosuppression, dry mouth and throat, fever, dry stools. This was inferred hot nature anticancer drug. |
Recommendations | Cold: Anemarrhena asphodeloides; Urena lobataL; Artemisia scoparia; Swertia mussotii; Swertia pseudochinensis; Gentiana manshurica; Gossampinus malabarica; Pyrrosia sheareri; Pyrrosia sheareri; Iris domestica; Gentiana scabra; Pyrrosia sheareri; Pyrrosia petiolosa |
Reference | ADReCS-Target: target profiles for aiding drug safety research and application. Nucleic Acids Res. 2018 Jan 4;46(D1):D911-D917. doi: 10.1093/nar/gkx899. ref_link |
Pair Name | Deoxyelephantopin, Cisplatin | |||
Disease Info | [ICD-11: 2C30] | Melanoma | Investigative | |
Biological Phenomena | Induction-->Blockade of cell cycle in G2/M phase | |||
Gene Regulation | Down-regulation | Expression | CCNA2 | hsa890 |
Down-regulation | Expression | CCND1 | hsa595 | |
Down-regulation | Expression | CDK1 | hsa983 | |
Down-regulation | Expression | MMP9 | hsa4318 | |
Up-regulation | Expression | TP53 | hsa7157 | |
In Vitro Model | B16 | Mouse melanoma | Mus musculus (Mouse) | CVCL_F936 |
In Vivo Model | The other six groups of mice were intravenously (i.v.) injected with 1×10⁵ B16 cells in 200 μl PBS through the tail vein at day 0. | |||
Result | The CP and DET combination may be an effective intervention for melanoma with reduced side effects. |
No. | Title | Href |
---|---|---|
1 | Phyto-sesquiterpene lactone deoxyelephantopin and cisplatin synergistically suppress lung metastasis of B16 melanoma in mice with reduced nephrotoxicity. Phytomedicine. 2019 Mar 15;56:194-206. doi: 10.1016/j.phymed.2018.11.005. | Click |